Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 5.02 · 8-K

Omega Healthcare Investors Inc.

OHINYSEEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously disclosed, effective October 1, 2026, the Board of Directors (the “Board”) of Omega Healthcare Investors, Inc. (the “Company”) appointed Matthew P.…

Filed Oct 1, 2026Accepted Oct 1, 2026, 8:20 AM EDTCIK 888491Accession 0001104659-26-112589
Share

Company context

Current securities

Recent company filings

  1. Regulation FD DisclosureOct 5, 2026
  2. SCHEDULE 13G - filed by COHEN & STEERS, INC. regarding OMEGA HEALTHCARE INVESTORS INCAug 14, 2026
  3. 10-Q filingJul 30, 2026
  4. Results of Operations and Financial ConditionJul 29, 2026
  5. 4 filingJun 9, 2026

Registered securities in this filing

OMEGA HEALTHCARE INVESTORS, INC. · 8-K · Filed 2026-10-01

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, $.10 par value

Symbol
OHI
Exchange
NYSE
Classification
COMMON
Status
Current
Filing context

Context: AsOf2026-10-01

Dimensions: Not supplied

Accession 000110465926112589 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 5.02

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously disclosed, effective October 1, 2026, the Board of Directors (the “Board”) of Omega Healthcare Investors, Inc. (the “Company”) appointed Matthew P. Gourmand, the Company’s President, to serve as the Company’s President and Chief Executive Officer, to succeed C. Taylor Pickett as Chief Executive Officer upon Mr. Pickett’s retirement. In connection therewith, also effective October 1, 2026, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Mr. Gourmand as a director of the Company to fill the vacancy created by Mr. Pickett’s retirement from the Board for the remaining term of Mr. Pickett’s directorship expiring in 2027. Mr. Pickett’s retirement is not the result of any disagreement with the Company on any matter related to the Company’s operations, policies or practices. Following Mr. Gourmand’s appointment, the number of directors constituting the entire Board remains at eight. As of the time of this filing, the Board does not expect to appoint Mr. Gourmand to any committees of the Board. Mr. Gourmand (age 51) has served as the Company’s President since January 1, 2025. Prior to that, Mr. Gourmand had served as the Company’s Senior Vice President of Corporate Strategy & Investor Relations since January 2021 and, prior to that, as the Company’s Senior Vice President of Investor Relations since October 2017. Prior to joining the Company, Mr. Gourmand spent ten years as an equity portfolio manager at Millennium Partners and Stevens Capital Management, three years as an equity research analyst at UBS and six years in the audit department of Deloitte, where he qualified as a Chartered Accountant and a Certified Public Accountant. He earned an LLB in Law from University College, London, and holds the Chartered Financial Analyst designation. Mr. Gourmand does not have any family relationship with any director, executive officer or person chosen to become a director or executive officer of the Company, and there are no arrangements or understandings between Mr. Gourmand and any other person(s) pursuant to which he was selected to become an officer or director of the Company. There are no related party transactions between Mr. Gourmand and the Company required to be disclosed under Item 404(a) of Regulation S-K. Mr. Gourmand will not receive any separate compensation for his service as a director beyond the compensation provided under his employment agreement with the Company.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.